Literature DB >> 17454999

Would we rather lose our life than lose our self? Lessons from the Dutch debate on euthanasia for patients with dementia.

Cees M P M Hertogh1, Marike E de Boer, Rose-Marie Dröes, Jan A Eefsting.   

Abstract

This article reviews the Dutch societal debate on euthanasia/assisted suicide in dementia cases, specifically Alzheimer's disease. It discusses the ethical and practical dilemmas created by euthanasia requests in advance directives and the related inconsistencies in the Dutch legal regulations regarding euthanasia/assisted suicide. After an initial focus on euthanasia in advanced dementia, the actual debate concentrates on making euthanasia/assisted suicide possible in the very early stages of dementia. A review of the few known cases of assisted suicide of people with so-called early dementia raises the question why requests for euthanasia/assisted suicide from patients in the early stage of (late onset) Alzheimer's disease are virtually non-existent. In response to this question two explanations are offered. It is concluded that, in addition to a moral discussion on the limits of anticipatory choices, there is an urgent need to develop research into the patient's perspective with regard to medical treatment and care-giving in dementia, including end-of-life care.

Entities:  

Mesh:

Year:  2007        PMID: 17454999     DOI: 10.1080/15265160701220881

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  13 in total

1.  [Physician-assisted suicide in dementia?].

Authors:  H Lauter
Journal:  Nervenarzt       Date:  2011-01       Impact factor: 1.214

2.  Health Care Professionals' Attitudes About Physician-Assisted Death: An Analysis of Their Justifications and the Roles of Terminology and Patient Competency.

Authors:  Derek W Braverman; Brian S Marcus; Paul G Wakim; Mark R Mercurio; Gary S Kopf
Journal:  J Pain Symptom Manage       Date:  2017-07-15       Impact factor: 3.612

3.  The will to live instead of euthanasia: neurodegenerative diseases as seen by the sufferers themselves.

Authors:  Hans Förstl
Journal:  Dtsch Arztebl Int       Date:  2008-06-06       Impact factor: 5.594

4.  Dementia and assisted suicide and euthanasia.

Authors:  Inez D de Beaufort; Suzanne van de Vathorst
Journal:  J Neurol       Date:  2016-03-26       Impact factor: 4.849

5.  Should Medical Assistance in Dying Be Extended to Incompetent Patients With Dementia? Research Protocol of a Survey Among Four Groups of Stakeholders From Quebec, Canada.

Authors:  Gina Bravo; Claudie Rodrigue; Vincent Thériault; Marcel Arcand; Jocelyn Downie; Marie-France Dubois; Sharon Kaasalainen; Cees M Hertogh; Sophie Pautex; Lieve Van den Block
Journal:  JMIR Res Protoc       Date:  2017-11-13

6.  Clinical Considerations in Physician-Assisted Death for Probable Alzheimer's Disease: Decision-Making Capacity, Anosognosia, and Suffering.

Authors:  Jaime D Mondragón; Latife Salame; Arnoldo Kraus; Peter Paul De Deyn
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2019-06-18

7.  First prosecution of a Dutch doctor since the Euthanasia Act of 2002: what does the verdict mean?

Authors:  Eva Constance Alida Asscher; Suzanne van de Vathorst
Journal:  J Med Ethics       Date:  2019-12-05       Impact factor: 2.903

8.  Clown's view as respiciō: looking respectfully to and after people with dementia.

Authors:  Ruud Hendriks
Journal:  Med Health Care Philos       Date:  2017-06

9.  Bioethical implications of end-of-life decision-making in patients with dementia: a tale of two societies.

Authors:  Jaime D Mondragón; Latife Salame-Khouri; Arnoldo S Kraus-Weisman; Peter P De Deyn
Journal:  Monash Bioeth Rev       Date:  2020-05

10.  Euthanasia requests in dementia cases; what are experiences and needs of Dutch physicians? A qualitative interview study.

Authors:  Jaap Schuurmans; Romy Bouwmeester; Lamar Crombach; Tessa van Rijssel; Lizzy Wingens; Kristina Georgieva; Nadine O'Shea; Stephanie Vos; Bram Tilburgs; Yvonne Engels
Journal:  BMC Med Ethics       Date:  2019-10-04       Impact factor: 2.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.